Vanderbilt researchers have discovered that low dietary potassium causes direct kidney injury, suggesting potential new targets for treating chronic kidney disease.

Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.

Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.

Blocking the EGF receptor signaling pathway in immune system macrophages represents a new target for improving insulin resistance in people with obesity.

Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity.

Heidi Schaefer, MD, has been named medical director of the Adult Solid Organ Transplant Center at Vanderbilt University Medical Center.